The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, April 2021

Altmetric Badge

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review

Article in Expert Opinion on Drug Metabolism & Toxicology (May 2024)

Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation

Article in Journal of Clinical Medicine (April 2024)

The Effect of ABCB1 and CES1 Polymorphisms on Plasma Levels of Dabigatran and Risk of Hemorrhagic Complications in Ischemic Stroke Patients.

Article in American Journal of Therapeutics (March 2024)